PMID- 19952015
OWN - NLM
STAT- MEDLINE
DCOM- 20100604
LR  - 20191210
IS  - 1569-9285 (Electronic)
IS  - 1569-9285 (Linking)
VI  - 10
IP  - 3
DP  - 2010 Mar
TI  - Mid-term evaluation of Sorin Soprano bioprostheses in patients with a small 
      aortic annulus <or=20 mm.
PG  - 399-402
LID - 10.1510/icvts.2009.217844 [doi]
AB  - We set to examine the mid-term outcome after aortic valve replacement (AVR) with 
      Soprano pericardial stented bioprosthesis measuring <or=20 mm. Sixty-eight 
      patients underwent AVR between June 2003 and January 2006 (50 women; median age 
      77 years; range 60-89 years). Preoperatively, 60 patients (88.2%) were in New 
      York Heart Association (NYHA) class III/IV. The mean EuroSCORE was 6.7+/-2.3. 
      Supra-annular aortoplasty was performed in 21 patients (30.9%), out of which 11 
      patients received an 18 mm prosthesis (55%). The median follow-up was 45.5 months 
      (0.1-62 months). The 30-day mortality was 4.4% (n=3) with no early valve-related 
      deaths. No patient suffered a cerebrovascular accident and no patient required 
      replacement of prosthesis for coronary malperfusion. Postoperatively, the mean 
      gradient across the 18 mm bioprosthesis (n=20) was 25+/-8.9 mmHg and across the 
      20 mm bioprosthesis (n=48) was 25.5+/-7.3 mmHg (P=NS). During follow-up, there 
      was no valve-related death, re-operation for structural valve degeneration, 
      endocarditis or valve thrombosis. There were five late deaths and actuarial 
      survival at three and five years was 92.7+/-3.1% and 81.0+/-6.9%, respectively. 
      At last follow-up, 86.7% (n=52) of survivors were in NYHA class I/II. AVR with 
      Soprano bioprosthesis measuring <or=20 mm is associated with excellent mid-term 
      outcome. Continued follow-up is required to determine the long-term efficacy of 
      the prosthesis.
FAU - Vohra, Hunaid A
AU  - Vohra HA
AD  - Wessex Cardiothoracic Centre, Southampton University Hospitals NHS Trust, 
      Southampton, UK.
FAU - Whistance, Robert N
AU  - Whistance RN
FAU - Bolgeri, Marco
AU  - Bolgeri M
FAU - Velissaris, Theodore
AU  - Velissaris T
FAU - Tsang, Geoffrey M K
AU  - Tsang GM
FAU - Barlow, Clifford W
AU  - Barlow CW
FAU - Ohri, Sunil K
AU  - Ohri SK
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
DEP - 20091201
PL  - England
TA  - Interact Cardiovasc Thorac Surg
JT  - Interactive cardiovascular and thoracic surgery
JID - 101158399
SB  - IM
CIN - Interact Cardiovasc Thorac Surg. 2010 Mar;10(3):402. PMID: 20185844
MH  - Aged
MH  - Aged, 80 and over
MH  - Aortic Valve/pathology/physiopathology/*surgery
MH  - Aortic Valve Stenosis/mortality/pathology/physiopathology/*surgery
MH  - *Bioprosthesis
MH  - Female
MH  - *Heart Valve Prosthesis
MH  - Heart Valve Prosthesis Implantation/adverse effects/*instrumentation/mortality
MH  - Hemodynamics
MH  - Humans
MH  - Kaplan-Meier Estimate
MH  - Male
MH  - Prosthesis Design
MH  - Retrospective Studies
MH  - Time Factors
MH  - Treatment Outcome
EDAT- 2009/12/03 06:00
MHDA- 2010/06/05 06:00
CRDT- 2009/12/03 06:00
PHST- 2009/12/03 06:00 [entrez]
PHST- 2009/12/03 06:00 [pubmed]
PHST- 2010/06/05 06:00 [medline]
AID - icvts.2009.217844 [pii]
AID - 10.1510/icvts.2009.217844 [doi]
PST - ppublish
SO  - Interact Cardiovasc Thorac Surg. 2010 Mar;10(3):399-402. doi: 
      10.1510/icvts.2009.217844. Epub 2009 Dec 1.